H Ludwig

1.3k total citations
34 papers, 957 citations indexed

About

H Ludwig is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, H Ludwig has authored 34 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in H Ludwig's work include Cancer Treatment and Pharmacology (6 papers), Erythropoietin and Anemia Treatment (5 papers) and Cancer Research and Treatments (3 papers). H Ludwig is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Erythropoietin and Anemia Treatment (5 papers) and Cancer Research and Treatments (3 papers). H Ludwig collaborates with scholars based in Austria, Switzerland and Germany. H Ludwig's co-authors include N. Reed Dunnick, Eli Glatstein, Michael Schneider, Malcolm A. Bagshaw, Don R. Goffinet, Peter Reichardt, H. Lurie, Franco Buzzi, H.A. Chaudri and N. J. O’Higgins and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gut.

In The Last Decade

H Ludwig

32 papers receiving 906 citations

Peers

H Ludwig
Comparison fields: 5 of 89
  • Hematology 333
  • Oncology 326
  • Genetics 205
  • Cancer Research 192
  • Genetics 164
Replace Shinsaku Hirosawa with:
Shinsaku Hirosawa Japan
Takashi Kaneko Japan
Robert E. Rydell United States
AnneMarie W. Block United States
Martine George United States
Mackenzie Bowman Canada
Sabine Pomplun United Kingdom
Eleanor V. Willett United Kingdom
David Topolsky United States
Ida Casorelli Italy
Shinsaku Hirosawa Japan View profile →
Citations per field, relative to H Ludwig
H Ludwig · 1×
Citations per year, relative to H Ludwig
H Ludwig · 1×

Countries citing papers authored by H Ludwig

Since Specialization
Citations

This map shows the geographic impact of H Ludwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Ludwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Ludwig more than expected).

Fields of papers citing papers by H Ludwig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Ludwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Ludwig. The network helps show where H Ludwig may publish in the future.

Co-authorship network of co-authors of H Ludwig

This figure shows the co-authorship network connecting the top 25 collaborators of H Ludwig. A scholar is included among the top collaborators of H Ludwig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Ludwig. H Ludwig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 58
2
Use of Erythropoiesis-stimulating Agents (ESAs) in Lung Cancer Patients: Study-level and Patient-level Meta-analyses of Safety Outcomes
1
3 20
4 184
5
0
6 206
7 22
8
[Smoking and the risk of cancer].
8
9 5
10 5
11 3
12 77
13 1
14 2
15
[Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 2. Preoperative studies and follow-up].
1
16 32
17
Collagen-induced acute synovitis in collagen-immunized rabbits.
5
18
[Autoimmune phenomena in D-penicillamine therapy].
3
19 132
20
Q fever hepatitis.
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026